AdaptHealth Gelecekteki Büyüme

Future kriter kontrolleri 3/6

AdaptHealth kazanç ve gelirin sırasıyla yıllık 94% ve 3.5% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 90.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 10.8% olacağı tahmin edilmektedir.

Anahtar bilgiler

94.0%

Kazanç büyüme oranı

90.4%

EPS büyüme oranı

Healthcare kazanç büyümesi	21.1%
Gelir büyüme oranı	3.5%
Gelecekteki özkaynak getirisi	10.8%
Analist kapsamı	Good
Son güncelleme	15 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt

Nov 13

Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)

Oct 22

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Sep 06

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

Jul 14

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Mar 07

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Feb 16

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Jan 18

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

Nov 15

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Oct 18

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Sep 27

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Jul 19

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Jul 04

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Jun 16

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Apr 10

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Mar 22

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Feb 23

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Jan 24

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet

Dec 16

We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease

Nov 28

AdaptHealth named a Fresh Pick at Baird after investor day

Sep 19

AdaptHealth: Operating Performance Stretching Up, Valuation Less So

Aug 30

AdaptHealth Q2 2022 Earnings Preview

Aug 08

AdaptHealth gains ahead of addition to S&P SmallCap 600

Aug 02

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Jun 27

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:AHCO - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	3,521	151	N/A	N/A	6
12/31/2025	3,341	120	232	530	9
12/31/2024	3,233	75	176	476	8
9/30/2024	3,263	-218	229	547	N/A
6/30/2024	3,261	-690	166	501	N/A
3/31/2024	3,248	-695	53	389	N/A
12/31/2023	3,200	-679	143	481	N/A
9/30/2023	3,122	-427	31	422	N/A
6/30/2023	3,075	42	22	431	N/A
3/31/2023	3,009	40	44	448	N/A
12/31/2022	2,971	63	-18	374	N/A
9/30/2022	2,903	87	66	378	N/A
6/30/2022	2,800	125	20	298	N/A
3/31/2022	2,689	184	79	324	N/A
12/31/2021	2,465	142	72	276	N/A
9/30/2021	2,115	40	68	225	N/A
6/30/2021	1,746	-64	124	232	N/A
3/31/2021	1,361	-131	122	190	N/A
12/31/2020	1,071	-162	156	196	N/A
9/30/2020	858	-91	133	163	N/A
6/30/2020	710	-44	124	145	N/A
3/31/2020	602	-50	45	69	N/A
12/31/2019	530	-21	39	60	N/A
9/30/2019	489	-8	52	68	N/A
6/30/2019	454	8	57	72	N/A
3/31/2019	398	14	61	73	N/A
12/31/2018	345	23	58	68	N/A
12/31/2017	193	10	N/A	46	N/A
12/31/2016	174	-4	N/A	30	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AHCO önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.6% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: AHCO önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: AHCO önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: AHCO şirketinin gelirinin (yıllık 3.5% ) US pazarından (yıllık 8.9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: AHCO şirketinin gelirinin (yıllık 3.5% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AHCO 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 10.8 %).

AdaptHealth Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

AdaptHealth Corp. Updates Financial Guidance for Fiscal Year 2024

AdaptHealth Corp. Updates Financial Guidance for the Fiscal Year 2024

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Consensus EPS estimates fall by 34%

Price target decreased by 8.7% to US$10.50

Recent updates

We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt

Third quarter 2024 earnings: EPS misses analyst expectations

AdaptHealth Corp. Updates Financial Guidance for Fiscal Year 2024

Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)

AdaptHealth Corp. Appoints Diana Nole to Board of Directors

AdaptHealth Corp. to Report Q3, 2024 Results on Nov 05, 2024

Insufficient new directors

Insider recently sold US$281k worth of stock

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Adapthealth Corp. Announces Scott Barnhart as Chief Operating Officer, Effective September 23, 2024

AdaptHealth Corp. Announces Executive Changes

Second quarter 2024 earnings: EPS misses analyst expectations

AdaptHealth Corp. Updates Financial Guidance for the Fiscal Year 2024

AdaptHealth Corp. to Report Q2, 2024 Results on Aug 06, 2024

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

AdaptHealth Corp. Announces Changes to Board of Directors and Management

Levi & Korsinsky LLP Encourages to File a Claim Against the Settlement Fund Before Deadline Against Adapthealth Corp

AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement

Jerry W. Ray V. AdaptHealth Corp. Class Action Reaches Important Milestones

AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Chief Technology Officer notifies of intention to sell stock

Insufficient new directors

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

Consensus EPS estimates fall by 34%

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Price target decreased by 8.7% to US$10.50

Rosen Law Firm Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

New minor risk - Share price stability

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Investor sentiment deteriorates as stock falls 16%

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Adapthealth Corp. Announces CEO Changes

Investor sentiment deteriorates as stock falls 17%

Chief Technology Officer notifies of intention to sell stock

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Price target increased by 8.3% to US$17.03

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Investor sentiment improves as stock rises 18%

Adapthealth Corp. Announces CEO Changes

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Consensus EPS estimates increase by 13%, revenue downgraded

First quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 19% to US$17.83

AdaptHealth Corp. Announces Stephen Griggs Not to Seek Re-Election to the Board

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Consensus EPS estimates fall by 35%

Investor sentiment deteriorates as stock falls 32%

Price target decreased by 17% to US$23.60

Full year 2022 earnings: EPS misses analyst expectations

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Insider recently sold US$941k worth of stock